Toremifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C26H28ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7NFE54O27T, chemically known as 2-(p-((z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethylethylamine citrate (1:1) but more generally known as toremifene, which bears US NIH Compound Identifier 3005572. European Medicines Agency schedules Toremifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11197MIG. The term TOREMIFENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules toremifene in its Anatomical Therapeutic Chemical (ATC) Classification. TOREMIFENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule toremifene under HS 29221980 and SITC 51461. As of Q4 2014, TOREMIFENE remains US FDA's Preferred Term for this commodity. Toremifene bears US NLM identifiers UMLS ID C0076836 and NCI Concept Code C1256. SMILES: CLCC/C(=C(/C1CCC(OCCN(C)C)CC1)C1CCCCC1)C1CCCCC1.OC(CC(=O)O)(CC(=O)O)C(=O)O.